Papa Giovanni XXIII Hospital
29
2
3
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.9%
2 terminated/withdrawn out of 29 trials
88.9%
+2.4% vs industry average
0%
0 trials in Phase 3/4
6%
1 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (29)
Overviewing Real-World Outcomes to Boost Interventional Management of CAlcified Coronary Lesions: the OROBICA Registry.
Role: lead
Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib
Role: collaborator
Bedside PEEP Selection in by Electrical Impedence Tomography During Mechanical Ventilation in Children
Role: lead
Phrenic Infiltration as Cryoanalgesia Adjuvant for Early Postoperative Pain Following the Nuss Procedure
Role: lead
Medical Images Collection Research
Role: collaborator
Comparison Between 2 Techniques for Lumbar-ESPB
Role: lead
Percutaneous Intercostal Cryoneuromodulation Onset Timing.
Role: lead
Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure
Role: collaborator
Lactate Values During Labour and Their Correlation With Maternal and Foetal Outcome
Role: lead
NEPHSTROM for Diabetic Kidney Disease
Role: collaborator
Telemedicine Home-based Management in Patients With CHF and Type 2 Diabetes
Role: collaborator
Erector Spinae Block Versus PENG Block for Hip Replacement
Role: lead
Cerebral Blood Flow: Helmet vs Oronasal Mask During Continuous Positive Airway Pressure Ventilation
Role: lead
Long Pressure Autoregulation Index
Role: lead
Continuous Quantified EEG in NeuroIntensive Care
Role: collaborator
High Flow Nasal Cannulae vs Venturi Mask in Respiratory Failure Due to Pneumonia
Role: lead
Ex Vivo Lung Perfusion in Bergamo Lung Transplant Program
Role: lead
HOPE With Cytokine Filtration in Liver Transplantation (Cyto-HOPE)
Role: lead
Registry of Coronavirus Complications - CORRELATION WITH GLYCOMIC PROFILE in COVID-19 Patients
Role: lead
Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV
Role: collaborator